The Wistar Institute

1992–2022 · research · R01

c-Myc Targets in the Pathogenesis of Human Cancers

Chi V. Dang · The Wistar Institute · funded by National Institutes of Health

$229.1kCancer, Hypoxia, and Metabolism

1991–2022 · research · R01

Regulation of R-loop Formation and Genome Stability by ADAR1

Kazuko Nishikura · The Wistar Institute · funded by National Institutes of Health

$479.5kRNA regulation and disease

1991–2022 · research · R01

Regulation of R-loop Formation and Genome Stability by ADAR1

Kazuko Nishikura · The Wistar Institute · funded by National Institutes of Health

$479.5kRNA regulation and disease

1991–2022 · research · R01

Regulation of R-loop Formation and Genome Stability by ADAR1

Kazuko Nishikura · The Wistar Institute · funded by National Institutes of Health

$479.5kRNA regulation and disease

1991–2023 · research · R01

Regulation of R-loop Formation and Genome Stability by ADAR1

Kazuko Nishikura · The Wistar Institute · funded by National Institutes of Health

$479.5kRNA regulation and disease

1990–2022 · research · R01

Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis

Chi V. Dang · The Wistar Institute · funded by National Institutes of Health

$363.2kCircadian rhythm and melatonin

1990–2020 · research · R01

Myc - Transcription and Apoptosis

Chi V. Dang · The Wistar Institute · funded by National Institutes of Health

$382.9k

1990–2025 · research · R01

Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis

Chi V. Dang · The Wistar Institute · funded by National Institutes of Health

$370.6k

1976–2027 · training · T32

Training Program in Basic Cancer Research

Alessandro Gardini · The Wistar Institute · funded by National Institutes of Health

$558.5k

1976–2027 · training · T32

Training Program in Basic Cancer Research

Alessandro Gardini · The Wistar Institute · funded by National Institutes of Health

$389.5k

1976–2022 · training · T32

Training Program in Basic Cancer Research

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$688.5k

1976–2022 · training · T32

Training Program in Basic Cancer Research

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$544.7k

1976–2022 · training · T32

Training Program in Basic Cancer Research

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$591.4k

1976–2027 · training · T32

Training Program in Basic Cancer Research

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$537.6k

1976–2022 · training · T32

Training Program in Basic Cancer Research

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$548.2k

1976–2022 · training · T32

Training Program in Basic Cancer Research

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$469.5k

1976–2027 · training · T32

Training Program in Basic Cancer Research

Alessandro Gardini · The Wistar Institute · funded by National Institutes of Health

$489.4k

cooperative agreement · U19

Production Development

Niranjan Y Sardesai · The Wistar Institute · funded by National Institutes of Health

program · P50

Administrative Core

Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health

program · P50

Biostatistics Core

Phyllis A. Gimotty · The Wistar Institute · funded by National Institutes of Health

program · P50

Career Development Program

Lynn M. Schuchter · The Wistar Institute · funded by National Institutes of Health

program · P50

Association of Inherited Variation in Immune Mediated Adverse Events and Respons

Katherine L. Nathanson · The Wistar Institute · funded by National Institutes of Health

cooperative agreement · U19

Protein Core

Shan Lu · The Wistar Institute · funded by National Institutes of Health

program · P50

Developmental Research Program

Robert H Vonderheide · The Wistar Institute · funded by National Institutes of Health

program · P50

Targeted Combination Therapy for Melanoma

Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health

cooperative agreement · U19

Cellular Responses

David B. Weiner · The Wistar Institute · funded by National Institutes of Health

program · P50

Autophagy Modulation for Melanoma Therapy

Ravi K Amaravadi · The Wistar Institute · funded by National Institutes of Health

cooperative agreement · U19

Humoral Responses

Guido Ferrari · The Wistar Institute · funded by National Institutes of Health

program · P50

Biospecimen and Pathology Core

Xiaowei Xu · The Wistar Institute · funded by National Institutes of Health

program · P50

Engineered T Cell Therapy for Melanoma

Robert H Vonderheide · The Wistar Institute · funded by National Institutes of Health